Results 321 to 330 of about 346,818 (384)

Development of alternative feed with seed and insect meal for sustainable production of rainbow trout (Oncorhynchus mykiss) and quality fillets

open access: yesJSFA reports, EarlyView.
Abstract Background Rainbow trout (Oncorhynchus mykiss) is a freshwater fish with an aquaculture industry widely distributed throughout the world, whose diet is based on fish meal (marine origin), with serious sustainability problems associated with the sector. The objective of the study was the inclusion of other flours as a protein source (insect and
Araceli Cortes‐García   +2 more
wiley   +1 more source

Differential immune responses to probiotic and pathogenic bacteria in normal and colitic patients

open access: bronze, 2000
Shri Pathmakanthan   +4 more
openalex   +1 more source

Enhancing sheep milk yogurt with prickly pear (Opuntia ficus‐indica L.) flours (peel and pulp): nutritional, techno‐functional, and sensory evaluation

open access: yesJournal of the Science of Food and Agriculture, EarlyView.
Abstract BACKGROUND The aim of the present work was to evaluate the chemical composition and characterize the physicochemical, techno‐functional and antioxidant properties of flours obtained from the peel and pulp of prickly pear and to assess the effect of their incorporation on the composition, physicochemical parameters, microbiology, antioxidant ...
Nuria Muñoz‐Tebar   +6 more
wiley   +1 more source

A probiotic approach identifies a Treg-centred immunoregulation via modulation of gut microbiota metabolites in people with multiple sclerosis and healthy individuals. [PDF]

open access: yesEBioMedicine
Träger C   +12 more
europepmc   +1 more source

The Gut‐Brain Axis in Parkinson disease: Emerging Concepts and Therapeutic Implications

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background The gut‐brain axis, i.e. the bidirectional communication system between the gut and the brain, has become of central importance in Parkinson disease (PD) research over the past 20 years. Aims We aimed to describe the milestones of the gut‐brain axis research in PD and the development of theories proposing the involvement of the ...
Elisa Menozzi   +2 more
wiley   +1 more source

Treatment Selection and Prioritization for the EJS ACT‐PD MAMS Trial Platform

open access: yesMovement Disorders, EarlyView.
Abstract Background There are currently no disease‐modifying therapies (DMTs) registered for Parkinson's disease (PD). The Edmond J. Safra Accelerating Clinical Trials in Parkinson Disease (EJS ACT‐PD) initiative will expedite clinical assessment of putative DMTs through a multi‐arm multistage (MAMS) trial, testing several treatments against a common ...
Cristina Gonzalez‐Robles   +29 more
wiley   +1 more source

Home - About - Disclaimer - Privacy